n,n-dimethylarginine has been researched along with Insulin Resistance in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 24 (36.36) | 29.6817 |
2010's | 39 (59.09) | 24.3611 |
2020's | 3 (4.55) | 2.80 |
Authors | Studies |
---|---|
Akin, S; Candemir, B; Demirci, I; Eser, M; Gulcelik, NE; Haymana, C; Meric, C; Sonmez, A; Yuksel, B | 1 |
Abdel-Latif, Y; Badawy, E; El-Laithy, N; El-Naggar, M; El-Waseef, M; Hassan, H; Hussein, J | 1 |
He, YL; Li, XM; Nie, F; Xiong, Y; Zhou, XK | 1 |
Ban, HJ; Cho, SB; Choi, JS; Jang, HB; Kim, HJ; Kim, KY; Lee, HJ; Lee, KT; Lee, W; Nam, MS; Park, SI | 1 |
Aydogdu, A; Azal, O; Basaran, Y; Demir, O; Demirci, I; Dinc, M; Haymana, C; Meric, C; Sonmez, A; Torun, D; Yesildal, F | 1 |
Arós, F; Bullo, M; Clish, C; Cofán, M; Corella, D; Dennis, C; Estruch, R; Fitó, M; Guasch-Ferré, M; Gutiérrez-Bedmar, M; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Papandreou, C; Razquin, C; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Sorlí, JV; Toledo, E; Wang, DD; Yu, E | 1 |
Artusi, C; Cecchet, D; Millioni, R; Plebani, M; Puricelli, L; Tessari, P; Vedovato, M; Vettore, M | 1 |
Bedenčič, K; Jerin, A; Poredoš, P; Žižek, B; Žižek, D | 1 |
Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
Bøtker, HE; Møller, N | 1 |
Golay, A; Kruszelnicka, O; Surdacki, A | 1 |
Caniglia, D; Chiarelli, F; De Leonibus, C; De Marco, S; Marcovecchio, ML; Mohn, A | 1 |
Dimitroulas, T; Hodson, J; Kitas, GD; Panoulas, VF; Sandoo, A; Smith, J | 1 |
Bayraktar, N; Göktaş, T; Gülcan Kurt, Y; Güler, İ; Hımmetoğlu, MÖ; Kiliç, N; Taner, MZ; Taşlipinar, A; Yaman, H; Yavuz Taşlipinar, M | 1 |
Chiarelli, F; Chiavaroli, V; de Giorgis, T; Giannini, C; Marcovecchio, ML; Mohn, A | 1 |
Alkim, C; Alkim, H; Bayram, M; Boga, S; Ergun, M; Koksal, AR; Neijmann, ST; Ozgon, G; Ozguven, MB | 1 |
Angulo, J; El Assar, M; Hernández, A; Pindado, ML; Rodríguez-Mañas, L; Ruiz de Adana, JC; Sánchez-Ferrer, A; Santos-Ruiz, M | 1 |
Huang, S; Jiang, X; Peng, W; Shao, K; Tang, Y; Xia, L; Zou, D | 1 |
Hidekazu, M; Ikee, R; Kobayashi, S; Maesato, K; Mano, T; Ohtake, T; Oka, M | 1 |
Zsuga, J | 1 |
Riga, M; Stefanadi, E; Stefanadis, C; Toutouzas, K | 1 |
Dogru, T; Erdem, G; Sonmez, A; Tasci, I; Yilmaz, MI | 1 |
Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
Andreozzi, F; Bruni, R; Di Cello, S; Galiano Leone, G; Greco, L; Maio, R; Pascale, A; Perticone, F; Perticone, M; Sciacqua, A; Sesti, G; Talarico, G | 1 |
Rosenson, RS; Thande, N | 1 |
Anderssohn, M; Böger, RH; Fourie, CM; Huisman, HW; Malan, L; Malan, NT; Schutte, AE; Schutte, R; Schwedhelm, E; Strimbeanu, S; van Rooyen, JM | 1 |
Asgarani, F; Esteghamati, A; Ghadiri-Anari, A; Karimi-Jafari, H; Khalilzadeh, O; Nakhjavani, M | 1 |
Agrawal, A; Ahmad, T; Ghosh, B; Mabalirajan, U | 1 |
Bennett, C; Dasarathy, S; Edmison, JM; Kalhan, SC; Kasumov, T; Lopez, R | 1 |
Akturk, M; Altinova, A; Arslan, M; Buyukkagnici, U; Danisman, N; Dincel, A; Mert, I; Sargin, A | 1 |
Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
Dain, A; Das, UN; Eynard, AR; Repossi, G | 1 |
Chung, MY; Hsu, CP; Lin, MW; Lin, SJ; Lu, TM | 1 |
Alarcón, LM; Contreras, A; Díaz, N; González, DR; Guzmán, L; Icaza, G; Leiva, E; Moore-Carrasco, R; Mujica, V; Palomo, I | 1 |
Kafkasli, A; Karabulut, AB; Sertkaya, AC; Turkcuoglu, I | 1 |
Cameron, JD; Moran, LJ; Strauss, BJ; Teede, HJ | 1 |
Galvano, F; Li Volti, G; Mangiameli, A; Salamone, F; Salomone, S; Siarkos, I; Sorrenti, V; Urso, V | 1 |
Bicchieri, L; Di Gennaro, C; Manfredi, G; Montanari, A; Palombi, F; Pellegrino, A; Pinelli, S; Saccani-Jotti, G; Sansoni, P; Venturi, N | 1 |
Bluck, LJ; Siervo, M | 1 |
Brinkworth, GD; Buckley, JD; Clifton, PM; Noakes, M; Norman, RJ; Thomson, RL | 1 |
Janas, R; Litwin, M; Niemirska, A; Płudowski, P; Skorupa, E; Sladowska-Kozłowska, J; Wawer, ZT; Wierzbicka, A | 1 |
Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y | 1 |
Alzamora, MT; Arenillas, JF; Barallat, J; Dávalos, A; Dorado, L; Galán, A; Hernández, M; Jiménez, M; López-Cancio, E; Massuet, A; Millán, M; Reverté, S; Suñol, A | 1 |
Bravo, G; del-Río-Navarro, BE; Hong, E; Huang, F; Navarro-Olivos, E; Pérez Ontiveros, JA; Ruiz-Bedolla, E; Villafaña, S | 1 |
Galal, O; Podlogar, J; Verspohl, EJ | 1 |
Dimitroulas, T; Hodson, J; Kitas, GD; Metsios, GS; Sandoo, A; Smith, JP; Stavropoulos-Kalinoglou, A; Veldhuijzen van Zanten, JJ | 1 |
Aravind, S; Balasubramanyam, M; Mohan, V; Monickaraj, F; Nandhini, P; Prabu, P; Sathishkumar, C | 1 |
Kurabayashi, M; Morita, H; Nagai, R; Nakamura, T; Saito, Y | 1 |
Fujii, H; Hiuge, A; Horio, T; Kamide, K; Kawano, Y; Nakatani, S; Ogihara, T; Rakugi, H; Takiuchi, S | 1 |
Arnesen, H; Eid, HM; Hjerkinn, EM; Lyberg, T; Seljeflot, I | 1 |
Bereczki, D; Gesztelyi, R; Kéki, S; Török, J; Zsuga, J | 1 |
Adegoke, OA; Chevalier, S; Gougeon, R; Lamarche, M; Marliss, EB; Morais, JA; Wu, G | 1 |
Artwohl, M; Baumgartner-Parzer, S; Bayerle-Eder, M; Mayer, BX; Mittermayer, F; Namiranian, K; Pleiner, J; Roden, M; Schaller, G; Wolzt, M | 1 |
Cooke, JP; Mondon, CE; Sydow, K | 1 |
Acikel, C; Bilgi, C; Caglar, K; Cakir, E; Eyileten, T; Kaya, A; Oguz, Y; Oktenli, C; Sonmez, A; Vural, A; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
Bode-Böger, SM; Dubiel, JS; Huszno, B; Kawecka-Jaszcz, K; Klecha, A; Martens-Lobenhoffer, J; Stochmal, A; Stochmal, E; Surdacki, A; Szurkowska, M; Szybiński, Z | 1 |
Böger, RH; Garcia, RG; López-Jaramillo, P; Maas, R; Perez, M; Schwedhelm, E | 1 |
Bereczki, D; Csiba, L; Gesztelyi, R; Kéki, S; Lenkei, A; Magyar, MT; Török, J; Valikovics, A; Zsuga, J; Zsuga, M | 1 |
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
Acikel, C; Caglar, K; Cakir, E; Eyileten, T; Kurt, Y; Oguz, Y; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
Kautzky-Willer, A; Langenberger, H; Mittermayer, F; Pacini, G; Pleiner, J; Schaller, G; Tura, A; Winzer, C; Wolzt, M | 1 |
Bekpinar, S; Can, A; Cetinalp-Demircan, P; Orhan, Y; Unlucerci, Y | 1 |
Heutling, D; Kaltwasser, P; Kleinstein, J; Krzyzanowska, K; Lehnert, H; Mittermayer, F; Nickel, I; Randeva, H; Schernthaner, G; Schulz, H; Westphal, S; Wolzt, M | 1 |
Cooke, JP; Konishi, H; Mondon, CE; Schrader, J; Sydow, K | 1 |
Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
Nash, DT | 1 |
5 review(s) available for n,n-dimethylarginine and Insulin Resistance
Article | Year |
---|---|
Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Topics: Animals; Arginine; Endothelium; Enzyme Inhibitors; Humans; Insulin Resistance; Nitric Oxide; Nitric Oxide Synthase | 2008 |
Emerging interface between metabolic syndrome and asthma.
Topics: Animals; Arginase; Arginine; Asthma; Humans; Hyperinsulinism; Inflammation; Insulin; Insulin Resistance; Metabolic Syndrome; Mice; Mitochondria; Nitric Oxide Synthase Type III; Somatomedins; Th2 Cells | 2011 |
L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes.
Topics: Animals; Antihypertensive Agents; Arginine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin Resistance; Nitric Oxide; Nitric Oxide Synthase Type III; Prognosis | 2011 |
[Involvement of homocysteine in the pathogenesis of hypertension and hypertensive target-organ damage].
Topics: Arginine; Arteriosclerosis; Biopterins; Cell Division; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hypertension; Insulin Resistance; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Risk Factors | 2004 |
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
Topics: Animals; Arginine; Cardiovascular Diseases; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase; Randomized Controlled Trials as Topic; Risk Factors; Vasodilation | 2005 |
7 trial(s) available for n,n-dimethylarginine and Insulin Resistance
Article | Year |
---|---|
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension.
Topics: Acetylcholine; Adult; Arginine; Case-Control Studies; Endothelium, Vascular; Female; Homeostasis; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Nitric Oxide Synthase Type III; Nitroprusside; Regional Blood Flow; Risk Factors; Vasodilator Agents | 2010 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Diet; Endothelium, Vascular; Exercise; Exercise Therapy; Female; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Overweight; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk; Vascular Cell Adhesion Molecule-1 | 2012 |
Free fatty acids do not acutely increase asymmetrical dimethylarginine concentrations.
Topics: Adult; Arginine; Blood Pressure; Endothelial Cells; Endothelium, Vascular; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Humans; Insulin Resistance; Male; Reference Values; Statistics, Nonparametric; Umbilical Veins | 2005 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Glomerular Filtration Rate; Hemorheology; Humans; Insulin Resistance; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan; Vasodilation | 2007 |
54 other study(ies) available for n,n-dimethylarginine and Insulin Resistance
Article | Year |
---|---|
Triglyceride-glucose index levels in patients with Klinefelter syndrome and its relationship with endothelial dysfunction and insulin resistance: a cross-sectional observational study.
Topics: Adult; Blood Glucose; Cross-Sectional Studies; Endothelial Cells; Humans; Insulin Resistance; Klinefelter Syndrome; Male; Testosterone; Triglycerides; Young Adult | 2023 |
Homocysteine and Asymmetrical Dimethylarginine in Diabetic Rats Treated with Docosahexaenoic Acid-Loaded Zinc Oxide Nanoparticles.
Topics: Animals; Arginine; Cellulose; Diabetes Mellitus, Experimental; Docosahexaenoic Acids; Homocysteine; Hyperhomocysteinemia; Insulin; Insulin Resistance; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Nitric Oxide; Rats; Risk Factors; Zinc Oxide | 2020 |
Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats.
Topics: Acetylcysteine; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radical Scavengers; Glycosylation; Heart Diseases; Insulin Resistance; Male; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Papillary Muscles; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2021 |
Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle.
Topics: Adolescent; Adult; Animals; Arginine; Biomarkers; Cohort Studies; Humans; Insulin Resistance; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Skeletal; Signal Transduction | 2018 |
Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome.
Topics: Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Endothelium, Vascular; Humans; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Klinefelter Syndrome; Male; Multivariate Analysis; Prevalence; Risk Factors; Testosterone; Turkey; Young Adult | 2018 |
Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial.
Topics: Aged; Aged, 80 and over; Arginine; Case-Control Studies; Citrulline; Cohort Studies; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Diet, Mediterranean; Female; Humans; Incidence; Insulin Resistance; Male; Middle Aged; omega-N-Methylarginine; Ornithine; Risk Factors | 2019 |
Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.
Topics: Adult; Age Factors; Aged; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged; Nitric Oxide | 2013 |
Effect of metabolic abnormalities on endothelial dysfunction in normotensive offspring of subject with hypertension.
Topics: Adiponectin; Adult; Arginine; Biomarkers; Brachial Artery; Case-Control Studies; Disease Progression; Female; Genetic Predisposition to Disease; Heredity; Humans; Hyperemia; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Pedigree; Phenotype; Risk Factors; Ultrasonography; Vasodilation | 2013 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
ON NO--the continuing story of nitric oxide, diabetes, and cardiovascular disease.
Topics: Arginine; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Male; Nitric Oxide | 2013 |
Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
Topics: Adult; Aged; Angina, Stable; Arginine; Biomarkers; Blood Glucose; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Humans; Insulin; Insulin Resistance; Linear Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Severity of Illness Index | 2013 |
Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy.
Topics: Arginine; Blood Glucose; Case-Control Studies; Child; Female; Follow-Up Studies; Growth Disorders; Hormone Replacement Therapy; Human Growth Hormone; Humans; Insulin Resistance; Lipid Metabolism; Lipids; Male; Puberty; Time Factors | 2014 |
Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.
Topics: Aged; Amidohydrolases; Analysis of Variance; Arginine; Arthritis, Rheumatoid; Female; Genetic Variation; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Risk Factors; Treatment Outcome | 2014 |
Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome.
Topics: Adult; Arginine; Body Mass Index; Endothelium, Vascular; Female; Humans; Insulin Resistance; Nitric Oxide; Polycystic Ovary Syndrome; Young Adult | 2014 |
Blood pressure from childhood to adolescence in obese youths in relation to insulin resistance and asymmetric dimethylarginine.
Topics: Adolescent; Adolescent Development; Arginine; Biomarkers; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Child; Child Development; Disease Progression; Female; Humans; Hypertension; Insulin Resistance; Italy; Lost to Follow-Up; Male; Pediatric Obesity; Prehypertension; Risk Factors; Severity of Illness Index | 2016 |
Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Insulin Resistance; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2015 |
Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.
Topics: Adipose Tissue; Adult; Aged; Animals; Arginase; Arginine; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Insulin Resistance; Male; Middle Aged; Obesity, Morbid; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Up-Regulation; Vasodilation | 2016 |
The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
Topics: Adiponectin; Aged; Apelin; Arginine; Atherosclerosis; Blood Glucose; Coronary Disease; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prediabetic State; Prognosis | 2016 |
Coronary artery calcification, ADMA, and insulin resistance in CKD patients.
Topics: Aged; Arginine; Calcinosis; Case-Control Studies; Chronic Disease; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Insulin Resistance; Kidney Diseases; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed | 2008 |
[Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Stenosis; Chromatography; Enzyme Inhibitors; Female; Homocysteine; Humans; Insulin Resistance; Linear Models; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography, Doppler, Color | 2008 |
Asymmetric dimethylarginine levels decrease because of insulin infusion: is it an unexpected finding?
Topics: Arginine; Humans; Insulin; Insulin Resistance | 2008 |
Vascular biomarkers in the metabolic syndrome.
Topics: Arginine; Biomarkers; Blood Vessels; Endothelium, Vascular; Enzyme Inhibitors; Glycation End Products, Advanced; Humans; Insulin Resistance; Metabolic Syndrome; Signal Transduction; Stem Cells | 2009 |
Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians.
Topics: Adult; Age Factors; Aged; Arginine; Black People; Blood Flow Velocity; Blood Glucose; Blood Pressure; Blood Vessels; Cross-Sectional Studies; Female; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Patient Selection; Pulsatile Flow; Regression Analysis; Sex Factors; South Africa; Vascular Resistance; White People | 2010 |
ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
Topics: Adiposity; Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diabetes Mellitus, Type 2; Fasting; Homeostasis; Humans; Inflammation; Insulin Resistance; Male; Middle Aged; Triglycerides | 2010 |
Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Biopsy; Blood Glucose; Chromatography, High Pressure Liquid; Fatty Liver; Female; Glomerular Filtration Rate; Humans; Insulin Resistance; Liver; Male; Middle Aged | 2011 |
Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes.
Topics: Adolescent; Adult; Arginine; C-Reactive Protein; Diabetes, Gestational; Female; Homocysteine; Humans; Insulin Resistance; Pregnancy; Pregnancy Trimester, Third; Young Adult | 2010 |
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Topics: Aged; Amidohydrolases; Analysis of Variance; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Linear Models; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Taiwan | 2011 |
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome.
Topics: Arginine; Body Mass Index; Case-Control Studies; Chile; Cholesterol, LDL; Female; Humans; Insulin Resistance; Lipid Peroxidation; Male; Malondialdehyde; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Oxidative Stress; Plasminogen Activator Inhibitor 1; Vascular Cell Adhesion Molecule-1; Waist Circumference | 2011 |
Asymmetric dimethylarginine level in hyperglycemic gestation.
Topics: Adult; Arginine; Blood Glucose; Body Mass Index; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes, Gestational; Early Diagnosis; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Reproducibility of Results; Spectrometry, Fluorescence | 2011 |
Vascular function in the diagnostic categories of polycystic ovary syndrome.
Topics: Adult; Arginine; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Overweight; Phenotype; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Resistance | 2011 |
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice.
Topics: Acetylcholine; Animals; Antioxidants; Aorta; Arginine; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Insulin Resistance; Liver; Male; Mice; Mice, Obese; Nitroprusside; Obesity; Phenylephrine; Silybin; Silymarin; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Endothelial dysfunction and high cardiovascular risk profile in severe alcoholics improve only partially following a medium-term alcohol withdrawal.
Topics: Adult; Age of Onset; Aged; Alcoholism; Arginine; Biomarkers; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Confidence Intervals; Endothelium, Vascular; Female; Heart Rate; Humans; Insulin Resistance; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Oxidative Stress; Risk Assessment; Smoking; Vasodilation | 2012 |
In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome.
Topics: Adult; Arginine; Blood Glucose; Blood Pressure; Cholesterol, HDL; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitrates; Nitric Oxide; Obesity; Saliva; Triglycerides; Waist Circumference | 2012 |
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.
Topics: Adiposity; Adolescent; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Biomarkers; Blood Pressure; C-Reactive Protein; Carotid Artery Diseases; Carotid Intima-Media Thickness; Chi-Square Distribution; Child; Child, Preschool; Cholesterol, LDL; Female; Glutathione Peroxidase; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoproteins, LDL; Male; Metabolic Syndrome; Oxidative Stress; Poland; Severity of Illness Index; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome | 2012 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Early Diagnosis; Endothelium, Vascular; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Predictive Value of Tests; Severity of Illness Index; Vascular Diseases; Vasodilation | 2013 |
Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cohort Studies; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Insulin Resistance; Intracranial Arteriosclerosis; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Plasminogen Activator Inhibitor 1; Regression Analysis; Resistin; Risk Factors; Spain | 2012 |
Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention.
Topics: Adolescent; Arginine; Body Mass Index; Child; Eating; Feeding Behavior; Female; Ghrelin; Humans; Insulin Resistance; Life Style; Male; Mexico; Obesity; Surveys and Questionnaires | 2013 |
Impact of ADMA (asymmetric dimethylarginine) on physiology with respect to diabetes mellitus and respiratory system BEAS-2B cells (human bronchial epithelial cells).
Topics: Animals; Arginine; Blood Glucose; Cell Line; Chemokine CXCL2; Diabetes Mellitus; Epithelial Cells; Female; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-6; Male; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Respiratory Mucosa; Trachea; Tumor Necrosis Factor-alpha | 2013 |
Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance.
Topics: Adult; Aged; Arginine; Arthritis, Rheumatoid; Female; Homeostasis; Humans; Insulin Resistance; Male; Middle Aged | 2013 |
Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Arginine; Biomarkers; Cell Differentiation; Gene Expression; Glucose; Glucose Oxidase; Hydrogen Peroxide; Insulin Resistance; Interleukin-6; Mice; Oxidative Stress; p21-Activated Kinases; Reactive Oxygen Species; Telomere; Telomere Shortening; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2013 |
Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.
Topics: Aged; Arginine; Coronary Circulation; Echocardiography, Doppler; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Male; Middle Aged | 2004 |
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking | 2004 |
Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition.
Topics: Animals; Arginine; Atherosclerosis; Biomarkers; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Insulin Resistance; Models, Biological; Nitric Oxide; Nitric Oxide Synthase | 2005 |
Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Blood Glucose; Body Composition; Female; Glucose; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Obesity; omega-N-Methylarginine; Proteins; Regression Analysis; Sex Characteristics | 2006 |
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Chronic Disease; Disease Progression; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Kidney Diseases; Male; Proteinuria; Regression Analysis | 2006 |
Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.
Topics: Adult; Aged; Arginine; Blood Glucose; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Discriminant Analysis; Female; Glucose Clamp Technique; Homocysteine; Humans; Insulin Resistance; Male; Middle Aged; Risk Factors; Triglycerides | 2007 |
Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome.
Topics: Adolescent; Adult; Arginine; C-Reactive Protein; Colombia; Humans; Insulin Resistance; Male; Metabolic Syndrome; White People | 2007 |
Dimethylarginines at the crossroad of insulin resistance and atherosclerosis.
Topics: Adult; Arginine; Atherosclerosis; Female; Humans; Insulin Resistance; Male; Middle Aged | 2007 |
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes.
Topics: Adult; Arginine; Body Mass Index; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Male; Nitric Oxide; Obesity; Pregnancy; Reference Values; Risk Factors; Sex Factors; Vasoconstriction; Vasodilation | 2007 |
Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease.
Topics: Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Insulin Resistance; Middle Aged; Obesity; Overweight; Premenopause; Regression Analysis; Risk Factors | 2007 |
Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Topics: Adult; Androgens; Arginine; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Cross-Sectional Studies; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric; Triglycerides; Waist-Hip Ratio | 2008 |
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity.
Topics: Amidohydrolases; Animals; Arginine; Female; Gene Expression; Glucose Tolerance Test; Glycogen; Humans; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Skeletal; Nitric Oxide; Recombinant Proteins | 2008 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |
Insulin resistance, ADMA levels, and cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Metabolic Syndrome; Nitric Oxide Synthase; Risk Factors | 2002 |